A Barrett's esophagus registry of over 1000 patients from a specialist center highlights greater risk of progression than population-based registries and high risk of low grade dysplasia

Diseases of the Esophagus

Volumn 28, Issue 2, 2015, Pages 121-126

  Picardo, S L ^a   O'Brien, M P ^a   Feighery, R ^a   O'Toole, D ^a   Ravi, N ^a   O'Farrell, N J ^a   O'Sullivan, J N ^a   Reynolds, J V ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

Barrett's esophagus; Esophageal adenocarcinoma; High grade dysplasia; Low grade dysplasia

Indexed keywords

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; DISEASE COURSE; DISEASE REGISTRY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOSCOPY; ESOPHAGUS DYSPLASIA; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; INCIDENCE; IRELAND; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; ADENOCARCINOMA; AGE DISTRIBUTION; BIOPSY; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; REGISTER; RISK; SEX RATIO; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADENOCARCINOMA; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; BIOPSY; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; HUMANS; INCIDENCE; IRELAND; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; RISK; SEX DISTRIBUTION;

EID: 84923525110     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/dote.12166     Document Type: Article

References (26)

1. Gatenby P A C, Caygill P J, Watson A, Murray L, Romero Y. Barrett's esophagus registries. Ann N Y Acad Sci 2011; 1232: 405-410.
2. Barrett G, Cassell J A, Peacock J L, Coleman M P. National survey of British public's views on use of identifiable medical data by the National Cancer Registry. BMJ 2006; 332: 1068-1072.
3. Cook M B, Chow W H, Devesa S S. Oesophageal cancer incidence in the United States by race, sex and histologic type. Br J Cancer 2009; 101: 855-859.
4. Steevens J, Botterweck A A, Dirx M J, van der Brandt P A, Schouten L J. Trends in incidence of oesophageal and stomach cancer subtypes in Europe. Eur J Gastroenterol Hepatol 2010; 22: 669-678.
5. Caygill C P, Reed P I, Johnston B J, Hill M J, Ali M H, Levi S. A single centre's 20 years' experience of columnar-lined (Barrett's) oesophagus diagnosis. Eur J Gastroenterol Hepatol 1999; 11: 1355-1358.
6. Ramus J R, Gatenby P A C, Caygill C P J, Winslet M C, Watson A. Surveillance of Barrett's columnar-lined oesophagus in the UK: endoscopic intervals and frequency of detection of dysplasia. Eur J Gastroenterol Hepatol 2009; 21: 636-641.
7. O'Connor J B, O'Connor J B, Falk G W, Richter J E. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol 1999; 94: 2037-2042.
8. Bhat S, Coleman H G, Yousef Y etal. Risks of malignant progression in Barrett's esophagus patients: results from a large population-based register. J Natl Cancer Inst 2011; 103: 1-9.
9. Murray L, Watson P, Johnston B etal. Risk of adenocarcinoma in Barrett's oesophagus: population based study. BMJ 2003; 327: 534-535.
10. de Johnge P J, van Blankenstein M, Looman C W, Casparie M K, Meijer G A, Kuipers E J. Risk of malignant progression in patient with Barrett's oesophagus. A Dutch nationwide cohort study. Gut 2010; 59: 1030-1036.
11. Thomas T, Abrams K R, De Caestrecker J S, Robinson R J. Meta analysis: cancer risk in Barrett's oesophagus. Aliment Pharmacol Ther 2007; 26: 1465-1477.
12. Youssef F, Caldwell C, Cantwell M M, Galway K, Johnston B T, Murray L. The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis. Am J Epidemiol 2008; 168: 237-249.
13. Sikkema M, de Yonge P J F, Steyerbergrg E W, Kuipers E J. Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2010; 8: 235-244.
14. Lagergren J. Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk? Gut 2005; 54 (Suppl 1): i1-i5.
15. Post P N, Siersema P D, Van Dekken H. Rising incidence of clinically evident Barrett's oesophagus in The Netherlands: a nation-wide registry of pathology reports. Scand J Gastroenterol 2007; 42: 17-22.
16. Hvid-Jensen F, Pederson L, Drewes A M, Sorensen H T, Fuch-Jensen P. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 2011; 365: 1375-1383.
17. Provenzale D, Schmidt C, Wong J B. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol 1999; 94: 2043-2053.
18. Coleman H G, Bhat S, Johnston B T, McManus D, Gavin A T, Murray L J. Tobacco smoking increases the risk of high-grade dysplasia and cancer among patients with Barrett's esophagus. Gastroenterology 2012; 142: 233-240.
19. Caygill C P, Johnston D A, Lopez M etal. Lifestyle factors and Barrett's esophagus. Am J Gastroenterol 2002; 97: 1328-1331.
20. Abnet C C, Freedman N D, Hollenbeck A R, Fraumeni J F Jr, Leitzmann M, Schatzkin A. A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma. Eur J Cancer 2008; 44: 465-471.
21. Healy L A, Ryan A M, Pidgeon G, Ravi N, Reynolds J V. Lack of differential pattern in central adiposity and metabolic syndrome in Barrett's esophagus and gastroesophageal reflux disease. Dis Esophagus 2010; 23: 386-391.
22. Gatenby P A, Caygill C P, Ramus J R, Charlett A, Fitzgerald R C, Watson A. Short segment columnar-lined oesophagus: an underestimated cancer risk? A large cohort study of the relationship between Barrett's columnar-lined oesophagus segment length and adenoacarcinoma risk. Eur J Gastroenterol Hepatol 2007; 19: 969-975.
23. Sharma P, Falk G W, Weston A P, Reker D, Johnston M, Sampliner R E. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2006; 4: 566-572.
24. Solaymani-Dodaran M, Logan R F, West J, Card T, Copeland C. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Gut 2004; 53: 1070-1074.
25. Oberg S, Wenner J, Johansson J, Walther B, Willén R. Barrett esophagus: risk factors for progression to dysplasia and adenocarcinoma. Ann Surg 2005; 242: 49-54.
26. Lim C H, Treanor D, Dixon M F, Axon A T. Low-grade dysplasia in Barrett's esophagus has a high rate of progression. Endoscopy 2007; 39: 581-587.